Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion

Virology

Volumn 393, Issue 1, 2009, Pages 135-143

  Hu, Lulin ^a   Ceresa, Brian P ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cell fusion; HPV16 E5; Protein localization

Indexed keywords

EPITOPE; PROTEIN E5; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL CYCLE; CELL FUSION; CELL MEMBRANE; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; CYTOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING;

CELL FUSION; CELL MEMBRANE; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS;

EID: 70349235320     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.07.034     Document Type: Article

References (45)

1. Bouvard V., Matlashewski G., Gu Z.M., Storey A., and Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology 203 (1994) 73-80
2. Bravo I.G., Crusius K., and Alonso A. The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes. Arch. Virol. 150 2 (2005) 231-246
3. CDC. In: Disease I. (Ed). Genital HPV Infection - CDC Fact Sheet (2007)
4. Chen E.H., and Olson E.N. Unveiling the mechanisms of cell-cell fusion. Science 308 (2005) 369-373
5. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Brit. J. Cancer 88 1 (2003) 63-73
6. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., and El Chissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6 (2005) 204
7. Conrad M., Goldstein D., Andresson T., and Schlegel R. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology 200 (1994) 796-800
8. Dinneen J.L., and Ceresa B.P. Constitutive activation of rab5 results in a ligand independent redistribution of the EGFR and attenuates its ability to signal. Traffic 5 8 (2004) 606-615
9. Disbrow G.L., Sunitha I., Baker C.C., Hanover J., and Schlegel R. Codon optimization of HPV-16 E5 gene enhances protein expression. Virology 311 (2003) 105-114
10. Disbrow G.L., Hanover J., and Schlegel R. Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J. Virol. 79 9 (2005) 5839-5846
11. Duelli D., and Lazebnik Y. Cell-to-cell fusion as a link between viruses and cancer. Nat. Rev. Cancer 7 (2007) 968-976
12. Duelli D.M., Padilla-Nash H.M., Berman D., Murphy K.M., Ried T., and Lazebnik Y. A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr. Biol. 17 (2007) 1-7
13. Gieswein C.E., Sharom F.J., and Wildeman A.G. Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. Virology 313 (2003) 415-426
14. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., Shah K.V., and Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92 9 (2000) 709-720
15. Gillison M.L., D'Souza G., Westra W., Sugar E., Xiao W., Begum S., and Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J. Natl. Cancer Inst. 100 6 (2008) 407-420
16. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 12 (1992) 5547-5551
17. Hu L., Plafker K., Henthorn J., and Ceresa B.P. A non-invasive technique for quantifying and isolating fused cells. Cytotechnology 58 3 (2008) 113-118
18. Hu L., Plafker K., Vorozhoko V., Zuna R.E., Hanigan M.H., Gorbsky G.J., Plafker S.M., Angeletti P.C., and Ceresa B.P. Human papillomavirus 16 E5 induces polyploidy by cell fusion. Virology 384 1 (2009) 125-134
19. Jones D.L., Alani R.M., and Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21 Cip1-mediated inhibition of cdk2. Genes Dev. 111 (1997) 2101-2111
20. Kabsch K., and Alonso A. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J. Virol. 76 (2002) 12162-12172
21. Leechanachai P., Banks L., Moreau F., and Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 7 1 (1992) 19-25
22. Leptak C., Ramon y Cajal S., Kulke R., Horwitz B.H., Riese D.J., Dotto G.P., and DiMaio D. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J. Virol. 65 12 (1991) 7078-7083
23. Martin I., and Ryuysschaert J.-M. Common properties of fusion peptides from diverse systems. Biosci. Rep. 20 6 (2000) 483-500
24. McCance D.J. Human papillomaviruses and cell signaling. Sci. STKE 29 (2005) 29
25. McMurray H.R., Nguyen D., Westbrook T.F., and McCance D.J. Biology of papillomaviruses. J. Exp. Path. 82 (2001) 15-33
26. Mittal K.R., Chan W., and Demopoulos R.L. Sensitivity and specificity of various morphological features of cervical condylomas. Arch. Pathol. Lab. Med. 114 (1990) 1038
27. Narisawa-Saito M., and Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 98 10 (2007) 1505-1511
28. Oelze I., Kartenbeck J., Crusius K., and Alonso A. Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line. J. Virol. 69 (1995) 4489-4494
29. Oetke C.E., Auvinen E., Pawlita M., and Alonso A. Human Papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch. Virol. 145 (2000) 2183-2191
30. Pim D., Collins M., and Banks L. Human Papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7 1 (1992) 27-32
31. Prasad C.J., Sheets E., Selig A.M., McArthur M.C., and Crum C.P. The bi-nucleated squamous cell: histologic spectrum and relationship to low-grade squamous intraepithelial lesions. Mod. Pathol. 6 3 (1993) 313-317
32. Riley R.R., Duensing S., Brake T., Munger K., Lambert P.F., and Arbeit J.M. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res. 63 4862-4871 (2003)
33. Schwartz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
34. Stoler M.H., Rhodes C.R., Whitbeck A., Wolinsky S.M., Chow L.T., and Broker T.R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23 2 (1992) 117-128
35. Stoppler M.C., Straight S.W., Tsao G., Schlegel R., and McCance D.J. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223 (1996) 251-254
36. Straight S.W., Hinkle P.M., Jewers R.J., and McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67 8 (1993) 4521-4532
37. Straight S.W., Herman B., and McCance D.J. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69 5 (1995) 3185-3192
38. Suprynowicz F.A., Disbrow G.L., Krawczyk E., Simic V., Lantzky K., and Schlegel R. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene 27 8 (2008) 1071-1078
39. Thomsen P., van Deurs B., Norrild B., and Kayser L. The HPV 16 E5 oncogene inhibits endocytic trafficking. Oncogene 19 (2000) 6023-6032
40. Tomakidi P., Cheng H., Kohl A., Komposch G., and Alonso A. Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes. Eur. J. Cell Biol. (2000) 407-412
41. Valle G.F., and Banks L. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J. Gen. Virol. 76 (1995) 1239-1245
42. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
43. Williams S.M.G., Disbrow G.L., Schlegel R., Lee D., Threadgill D.W., and Lambert P.F. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65 15 (2005) 6534-6542
44. Zhang B., Spandau D.F., and Roman A. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. J. Virol. 76 1 (2002) 220-231
45. Zhang B., Li P., Wang E., Brahmi Z., Dunn K.W., Blum J.S., and Roman A. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology 310 (2003) 100-108